CYP2C9 and infectious disease: Thanks to the aforementioned analysis, the current PGx biomarker spectrum in Greece spans across many medical specialties, such as oncology (CYP2D6, TPMT, DPYD), psychiatry (CYP2D6, CYP2C19), cardiology (CYP2D6, CYP2C9, VKORC1, SLCO1B1), and infectious diseases (CYP2B6) [14].